Covaxin covid-19 vaccine shows robust immune response
India’s indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response in its first phase clinical trials. A detailed immunogenicity response of the first
India’s indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response in its first phase clinical trials. A detailed immunogenicity response of the first
Russia has developed the first vaccine against the coronavirus. The announcement was made by President Vladimir Putin during a televised video conference call with government